Genitourinary Cancer
News
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
News
FDA approves olaparib for certain metastatic prostate cancers
News
First PARP inhibitor approved for metastatic prostate cancer
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital
News
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
News
Three months of COVID-19 may mean 80,000 missed cancer diagnoses
A backlog of 22 million canceled or postponed tests for five common cancers is expected by early June.
News
Cancer screening, monitoring down during pandemic
Use of some tests came to “a near standstill” in early April.
News
Excess cancer deaths predicted as care is disrupted by COVID-19
Conference Coverage
Antitumor treatment may increase risk of severe events in COVID-19 patients
Article
ASCO panel outlines cancer care challenges during COVID-19 pandemic
